The MedTech industry faces a rapidly changing healthcare ecosystem across the entire Asia Pacific region. This flux has ignited interest in different methods of assessing medical technologies to inform value-based decision-making, one of which is Health Technology Assessment.
In partnership with APACMed, IQVIA MedTech has recently launched a new white paper: The Evolving Health Technology Assessment for Medical Devices and Diagnostics in the Asia Pacific Region and Key Considerations for Value Assessment Frameworks.
This authoritative report addresses the different levels of understanding around which, when and how medical technologies should be evaluated and is ideal for agencies looking to grow their knowledge base in policy and reimbursement decision making.
Join us for an exclusive webinar on Tuesday, 12 May 2020, where we will hear from IQVIA Asia Pacific's Sirinthip Petcharapiruch and Boston Scientific's Virginia Priest as they share key takeaways from the paper and crucially discuss objectives and opportunities to collaboratively support value-driven medical technology assessments going forward.